AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2011
Mar 9, 2011
30786_dirs_2011-03-09_99249314-8d8c-4d79-bc2b-141f1fdf0e5c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2011-03-08
Reporting Person: GOETZ JOHN (Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-08 | Bio-Rad A Common Stock | M | 8327 | $28.61 | Acquired | 38532.2195 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-03-08 | Incentive Stock Option (right to buy) | $28.61 | M | 8327 | Disposed | 2012-02-06 | Bio-Rad A Commonn Stock (8327) | Direct |
Footnotes
F1: Includes 74.1166 and 69.2610 shares acquired under the Bio-Rad Laboratories employee stock purchase plan on September 30, 2010 and December 31, 2010, respectively.
F2: The option vested in five equal annual installments beginning on February 6, 2003.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13